Schedule 13G ownership disclosure

TriSalus Life Sciences Inc

Common Stock · CUSIP: 89680M101

Event date: 2024-12-30

Filing-level shares
2,000,588.00
Percent of class
6.56%
  • Utmost Group PLC

    Shares: 2,000,588.00 · Class: 6.56%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-002269
Form type
SCHEDULE 13G
Filer
TriSalus Operating Life Sciences, Inc.
CIK
CIK 1518906
Filed
Jan 10, 2025
Reporting period
Dec 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub